Skip to main content

March 2008, Vol 1, No 2

Perspectives
Risk Factors, Subjectivity, and Truth in Healthcare
Robert E. Henry
Read More
Practice Management
Patent Reform Proposals Raise the Stakes for Researchers, Manufacturers of Biologics
Shayna B. Kravetz, BSc, Rosemary Frei, MSc
Stakeholder Perspective
AHDB Stakeholder Perspective
by Thomas McCarter, MD, FACP
Read More
Practice Management
The Value of Biologics
Stakeholder Perspective
Value-Based Benefit— A Joint Effort
Read More
Original Research
When Novelty Is Not Enough
Michael F. Murphy, MD, PhD
Stakeholder Perspective
AHDB Stakeholder Perspective
Read More
Original Research
Asthma-The National Surveillance Data and the National Asthma Education and Prevention Program's Expert Panel Report 3
Thomas McCarter, MD, FACP
Stakeholder Perspective
AHDB Stakeholder Perspective
by Joseph G. Dizon, MD
Read More
FDA Approvals
Behind-the-Counter Drug Access
Mark Senak, JD
Read More
Practice Management
Kaiser Daily Health Policy Report
Read More
Practice Management
National Asthma Guidelines Updated
Read More

Results 1 - 8 of 8